CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients

被引：0
|
作者：
S Minuzzo
S Indraccolo
V Tosello
E Piovan
A Cabrelle
L Trentin
G Semenzato
A Amadori
机构：
[1] University of Padova,Department of Oncology and Surgical Sciences
[2] Azienda Ospedaliera,VIMM & Department of Clinical and Experimental Medicine
[3] Clinical Immunology Branch,undefined
[4] University of Padova,undefined
来源：
Leukemia | 2005年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1099 / 1101
页数：2
相关论文
共 50 条
  • [1] CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients
    Minuzzo, S
    Indraccolo, S
    Tosello, V
    Piovan, E
    Cabrelle, A
    Trentin, L
    Semenzato, G
    Amadori, A
    LEUKEMIA, 2005, 19 (06) : 1099 - 1101
  • [2] Alternative splicing of CD79a (Igα) and CD79b (Igβ) transcripts in human B-CLL cells
    Alfarano, A
    Circosta, P
    Vallario, A
    Camaschella, C
    Indraccolo, S
    Amadori, A
    Caligaris-Cappio, F
    MECHANISMS OF B CELL NEOPLASIA 1998, 1999, 246 : 241 - 248
  • [3] CD40 activation: potential for specific immunotherapy in B-CLL
    von Bergwelt-Baildon, M
    Maecker, B
    Schultze, J
    Gribben, JG
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 853 - 857
  • [4] The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis
    Cragg, MS
    Chan, HTC
    Fox, MD
    Tutt, A
    Smith, A
    Oscier, DG
    Hamblin, TJ
    Glennie, MJ
    BLOOD, 2002, 100 (09) : 3068 - 3076
  • [5] Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b
    Jahn, Lorenz
    Hombrink, Pleun
    Hassan, Chopie
    Kester, Michel G. D.
    van der Steen, Dirk M.
    Hagedoorn, Renate S.
    Falkenburg, J. H. Frederik
    van Veelen, Peter A.
    Heemskerk, Mirjam H. M.
    BLOOD, 2015, 125 (06) : 949 - 958
  • [6] Influence of CD40 ligation on apoptosis of B-CLL cells survival and in vitro
    Grdisa, M
    LEUKEMIA RESEARCH, 2003, 27 (10) : 951 - 956
  • [7] High CD79b Expression Predicts a Poor Outcome in B-Cell Chronic Lymphocytic Leukemia (B-CLL).
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Zucchetto, Antonella
    Buccisano, Francesco
    Simotti, Cristina
    Maurillo, Luca
    Gianni, Laura
    Bulian, Pietro
    Venditti, Adriano
    Coletta, Angela
    Niscola, Pasquale
    de Fabritiis, Paolo
    Gattei, Valter
    Amadori, Sergio
    BLOOD, 2008, 112 (11) : 386 - 386
  • [8] Gene expression profiling suggests that B-CLL B cells from only a subset of B-CLL patients derive from CD5+CD19+ peripheral B-cells.
    Messmer, D
    Messmer, BT
    Allen, SL
    Kolitz, J
    Vinciguerra, V
    Rai, KR
    Chiorazzi, N
    BLOOD, 2001, 98 (11) : 149A - 149A
  • [9] CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients
    Perez-Chacon, Gema
    Vargas, Juan A.
    Jorda, Julia
    Alvarez, Natalia
    Martin-Donaire, Trinidad
    Rosado, Silvia
    Losada-Fernandez, Ignacio
    Rebolleda, Nerea
    Perez-Aciego, Paloma
    LEUKEMIA & LYMPHOMA, 2007, 48 (01) : 147 - 157
  • [10] Responsiveness to CD40 monoclonal antibodies and clinical stage of B-CLL
    Jacob, A
    Pound, JD
    Challa, A
    Gordon, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 45 - 45
12345